SCHEMBL27002188

SCHEMBL27002188

COc1cc(C=O)cc(OC)c1SCCCCCF

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.44
▸ ALDH1A1 P00352 9/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HTR2C P28335 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ FDPS P14324 1/20 0.39
▸ MAPT P10636 5/20 0.39
▸ HPGD P15428 4/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.37
▸ TRIM24 O15164 1/20 0.37
▸ ALDH5A1 P51649 1/20 0.37
▸ ABAT P80404 1/20 0.37
▸ TRIM33 Q9UPN9 1/20 0.37
▸ APP P05067 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ AOX1 Q06278 1/20 0.34
▸ TTR P02766 1/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27002173 0.98 HTR2A (0.45) HTR2AALDH1A1TSHRHTR2CHTR2B
SCHEMBL27002045 0.85 ALDH1A1 (0.42) ALDH1A1TSHRFDPSMAPTHPGD
SCHEMBL27002089 0.84 ALDH1A1 (0.41) ALDH1A1TSHRFDPSMAPTHPGD
SCHEMBL27002006 0.83 ALDH1A1 (0.43) ALDH1A1TSHRFDPSMAPTHPGD
SCHEMBL27002052 0.83 ALDH1A1 (0.38) HTR2AALDH1A1TSHRHTR2CHTR2B
SCHEMBL27002179 0.81 ALDH1A1 (0.40) HTR2AALDH1A1TSHRHTR2CHTR2B
SCHEMBL27002161 0.80 VCP (0.49) HTR2AALDH1A1MAPTL3MBTL1TDP1
SCHEMBL27131900 0.80 VCP (0.49) HTR2AALDH1A1MAPTL3MBTL1TDP1
SCHEMBL27002017 0.79 ALDH1A1 (0.40) ALDH1A1TSHRFDPSMAPTHPGD
SCHEMBL11584615 0.78 ALDH1A1 (0.48) ALDH1A1TSHRFDPSMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166618-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME GILGAMESH PHARMACEUTICALS, INC. (US) 2024-05-23 — — US disclosed
CN-117642379-A Phenylalkylamines and methods of making and using the same 吉尔伽美什制药公司 2024-03-01 — — CN disclosed
EP-4305019-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME Gilgamesh Pharmaceuticals, Inc. (US) 2024-01-17 — — EP disclosed
WO-2022192781-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME GILGAMESH PHARMACEUTICALS, INC. (US) 2022-09-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166618-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME PNMT, HTR6, HTR2C HTR2A 11/4885ALDH1A1 1077/4885TSHR 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback